Therapeutic Occupancy Time [Regulatives / Guidelines]

posted by heritage – India, 2018-02-18 08:19 (2695 d 03:29 ago) – Posting: # 18432
Views: 4,100

Hi Helmut

Thank you for your reply

I need to learn three points

1. What should be design and patient population of the study? I found many studies on clinical trials.gov wherein patient was taken.

Can you advice any good articles to read wherein healthy were taken

2. T>MIC study can waive need to do clinical trial?

3. Is there any regulatory guidance available for T>MIC stud?

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,675 registered users;
38 visitors (0 registered, 38 guests [including 12 identified bots]).
Forum time: 12:48 CEST (Europe/Vienna)

Many people tend to look at programming styles and languages like religions:
if you belong to one, you cannot belong to others.
But this analogy is another fallacy.    Niklaus Wirth

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5